Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.

Zhou J, Quah JY, Ng Y, Chooi JY, Toh SH, Lin B, Tan TZ, Hosoi H, Osato M, Seet Q, Ooi AGL, Lindmark B, McHale M, Chng WJ.

Haematologica. 2019 Nov 7. pii: haematol.2019.230482. doi: 10.3324/haematol.2019.230482. [Epub ahead of print]

2.

IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in 1q21(amp) multiple myeloma.

Teoh PJ, Chung TH, Chng PYZ, Toh SHM, Chng WJ.

Haematologica. 2019 Aug 14. pii: haematol.2019.221176. doi: 10.3324/haematol.2019.221176. [Epub ahead of print]

4.

Mobile touch screen device use and associations with musculoskeletal symptoms and visual health in a nationally representative sample of Singaporean adolescents.

Toh SH, Coenen P, Howie EK, Mukherjee S, Mackey DA, Straker LM.

Ergonomics. 2019 Jun;62(6):778-793. doi: 10.1080/00140139.2018.1562107. Epub 2019 Apr 23.

PMID:
30575442
5.

MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells.

Xie Z, Chooi JY, Toh SHM, Yang D, Basri NB, Ho YS, Chng WJ.

Leukemia. 2019 Mar;33(3):739-748. doi: 10.1038/s41375-018-0300-0. Epub 2018 Nov 23.

PMID:
30470837
6.

Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia.

Chong PSY, Zhou J, Chooi JY, Chan ZL, Toh SHM, Tan TZ, Wee S, Gunaratne J, Zeng Q, Chng WJ.

Oncogene. 2019 Feb;38(9):1508-1519. doi: 10.1038/s41388-018-0526-3. Epub 2018 Oct 10.

PMID:
30305722
7.

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis.

Teoh PJ, An O, Chung TH, Chooi JY, Toh SHM, Fan S, Wang W, Koh BTH, Fullwood MJ, Ooi MG, de Mel S, Soekojo CY, Chen L, Ng SB, Yang H, Chng WJ.

Blood. 2018 Sep 20;132(12):1304-1317. doi: 10.1182/blood-2018-02-832576. Epub 2018 Jul 30.

PMID:
30061158
8.

NF-κB promotes the stem-like properties of leukemia cells by activation of LIN28B.

Zhou J, Chooi JY, Ching YQ, Quah JY, Toh SH, Ng Y, Tan TZ, Chng WJ.

World J Stem Cells. 2018 Apr 26;10(4):34-42. doi: 10.4252/wjsc.v10.i4.34.

9.

A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase.

Zhou J, Toh SH, Chan ZL, Quah JY, Chooi JY, Tan TZ, Chong PSY, Zeng Q, Chng WJ.

J Hematol Oncol. 2018 Mar 7;11(1):36. doi: 10.1186/s13045-018-0581-9.

10.

The associations of mobile touch screen device use with musculoskeletal symptoms and exposures: A systematic review.

Toh SH, Coenen P, Howie EK, Straker LM.

PLoS One. 2017 Aug 7;12(8):e0181220. doi: 10.1371/journal.pone.0181220. eCollection 2017. Review.

11.

Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.

Zhou J, Bi C, Ching YQ, Chooi JY, Lu X, Quah JY, Toh SH, Chan ZL, Tan TZ, Chong PS, Chng WJ.

J Hematol Oncol. 2017 Jul 11;10(1):138. doi: 10.1186/s13045-017-0507-y.

12.

A follow-up survey on the knowledge of age-related macular degeneration and its risk factors among Singapore residents after 5 years of nation-wide awareness campaigns.

Sanjay S, Chin YC, Teo HT, Ong SX, Toh SH, Khong MH, Yeo AC, Au Eong KG.

Ophthalmic Epidemiol. 2014 Aug;21(4):230-6. doi: 10.3109/09286586.2014.929708. Epub 2014 Jul 1.

PMID:
24983763
13.

A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma.

Toh SH, Prathipati P, Motakis E, Kwoh CK, Yenamandra SP, Kuznetsov VA.

BMC Genomics. 2011 Nov 30;12 Suppl 3:S24. doi: 10.1186/1471-2164-12-S3-S24. Epub 2011 Nov 30.

14.

Energy expenditure and enjoyment of small-sided soccer games in overweight boys.

Toh SH, Guelfi KJ, Wong P, Fournier PA.

Hum Mov Sci. 2011 Jun;30(3):636-47. doi: 10.1016/j.humov.2010.12.001. Epub 2011 Jan 20.

PMID:
21255856
15.

WSN based mobile u-healthcare system with ECG, blood pressure measurement function.

Chung WY, Lee SC, Toh SH.

Conf Proc IEEE Eng Med Biol Soc. 2008;2008:1533-6. doi: 10.1109/IEMBS.2008.4649461.

PMID:
19162964
16.

Antioxidative phenolic compounds from the roots of Rhodiola sachalinensis A. Bor.

Lee MW, Lee YA, Park HM, Toh SH, Lee EJ, Jang HD, Kim YH.

Arch Pharm Res. 2000 Oct;23(5):455-8.

PMID:
11059822
17.

Diarylheptanoids with in vitro inducible nitric oxide synthesis inhibitory activity from Alnus hirsuta.

Lee MW, Kim NY, Park MS, Ahn KH, Toh SH, Hahn DR, Kim YC, Chung HT.

Planta Med. 2000 Aug;66(6):551-3.

PMID:
10985083
18.

Inhibition of cyclooxygenase-2 expression by diarylheptanoids from the bark of Alnus hirsuta var. sibirica.

Lee MW, Kim JH, Jeong DW, Ahn KH, Toh SH, Surh YJ.

Biol Pharm Bull. 2000 Apr;23(4):517-8.

PMID:
10784440
19.

Diarylheptanoids from the leaves of Alnus hirsuta Turcz.

Lee MW, Park MS, Jeong DW, Kim KH, Kim HH, Toh SH.

Arch Pharm Res. 2000 Feb;23(1):50-3.

PMID:
10728657
20.
21.

Effect of hyperthyroidism and its treatment on bone mineral content.

Toh SH, Claunch BC, Brown PH.

Arch Intern Med. 1985 May;145(5):883-6.

PMID:
3838875
22.

Chest pain as a presentation of reactive hypoglycemia.

Bansal S, Toh SH, LaBresh KA.

Chest. 1983 Nov;84(5):641-2.

PMID:
6628023
23.

Effect of calcitonin treatment on the natural course of bone demineralization in Paget's disease.

Toh SH, Claunch BC, Brown PH.

J Clin Endocrinol Metab. 1983 Feb;56(2):405-9.

PMID:
6822644
24.

Noninvasive assessment of vascular disease in the lower limbs of diabetics.

Van de Water JM, Falchuk SC, Toh SH, Indech RB.

J Cardiovasc Surg (Torino). 1980 Jul-Aug;21(4):469-74.

PMID:
7419564
25.

[Sigmoidoscopic examinations on 483 cases with symptoms].

CHOI TS, TOH SH, CHUNG KS.

Kyoto Daigaku Kekkaku Kenkyusho Kiyo. 1962 Mar;5:195-203. Korean. No abstract available.

PMID:
13879129
26.

The treatment of amebic dysentery with paromomycin (humatin). A preliminary report.

MOFFETT HF, TOH SH.

Antibiotic Med Clin Ther (New York). 1960 Sep;7:569-70. No abstract available.

PMID:
14423223

Supplemental Content

Support Center